Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Sanofi India Ltd Financial Statements & Historical Data

Updated NSE: SANOFIBSE: 500674
Report details
Last Updated:
Author: |Social: XLinkedIn

Sanofi India Ltd: For the quarter ending Jun 2026, reported sales were ₹438 crore and the net profit was ₹84 crore. Sales rose 7.9% and profit rose 20.0% against Jun 2025. Operating margin improved to 26.7% in Dec 2025.

Calculated from the stored statements below · Reporting periods remain separate
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 9 October 2026, 9:28 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price2,945₹ per share
Reported P/E19.8Times
Book value per share359₹ per share
Reported ROCE57.5 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 9 October 2026, 9:28 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap6,779 Cr.
Current Price2,945
High / Low4,898/2,914
Stock P/E19.8
Book Value359
Dividend Yield2.55 %
ROCE57.5 %
ROE43.0 %
Face Value10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

FINANCIALS

Quarterly performance

For the quarter ending Jun 2026, reported sales were ₹438 crore and the net profit was ₹84 crore. Sales rose 7.9% and profit rose 20.0% against Jun 2025. Operating margin was 26.3%, 2.9 percentage points higher than Jun 2025. The business retained more operating profit from each rupee of sales; check whether the change persists across periods.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 515491469511464524515536406475420472438
Expenses 393377370374348404397364311341330330322
Operating Profit 1221141001371161201181729513490143115
OPM % 24%23%21%27%25%23%23%32%23%28%22%30%26%
Other Income 578277412121439-22346
Interest 1000000000100
Depreciation 9999991010991099
Profit before tax 1691861671691271131221659410283138112
Tax % 27%18%18%19%19%27%25%28%26%26%26%26%26%
Net Profit 123152138137103829112070766210384
EPS in Rs 53.4366.1759.8759.3944.9635.7439.7051.9630.2233.0426.8344.6136.30

Last Updated: September 29, 2026, 5:53 pm

FINANCIALS

Annual performance

For the year ending Dec 2025, reported sales were ₹1,837 crore and the net profit was ₹327 crore. Sales fell 8.7% and profit fell 21.0% against Dec 2024. Operating margin was 26.7%, 2.3 percentage points higher than Dec 2024. The business retained more operating profit from each rupee of sales; check whether the change persists across periods.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 12, 2026, 4:21 am

MetricDec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025TTM
Sales 1,9772,1932,3672,4602,7713,0712,9022,9572,7702,8512,0131,8371,805
Expenses 1,6391,8171,8321,9212,1462,4032,1862,1942,0662,0471,5221,3461,323
Operating Profit 339376535538625667716762704804491491483
OPM % 17%17%23%22%23%22%25%26%25%28%24%27%27%
Other Income 13121866798833455642048379-8-9
Interest 0021102222222
Depreciation 9711311910210310082674240373736
Profit before tax 3734814805156106006771,258864846531445436
Tax % 29%33%37%37%38%31%29%25%28%29%22%27%
Net Profit 264322304326381414478944621603414327324
EPS in Rs 114.61139.78132.26141.74165.48180.09207.65410.61269.83262.26179.78142.04140.78
Dividend Payout % 39%46%51%50%51%194%176%119%211%64%65%87%

YoY Net Profit Growth

Year
YoY Net Profit Growth (%)
Change in YoY Net Profit Growth (%)

No data available for trend analysis.

Growth

Compounded Sales Growth
10 Years:0%
5 Years:-8%
3 Years:-12%
TTM:2%
Compounded Profit Growth
10 Years:8%
5 Years:0%
3 Years:-9%
TTM:1%
Stock Price CAGR
10 Years:8%
5 Years:0%
3 Years:11%
1 Year:-31%
Return on Equity
10 Years:24%
5 Years:32%
3 Years:41%
Last Year:47%

Last Updated: September 5, 2025, 1:25 pm

FINANCIALS

Balance sheet

Reported borrowings stood at ₹15 crore in Jun 2026. Read the borrowing notes, repayment schedule and cash-flow statement together; the borrowing balance alone does not establish liquidity or repayment capacity.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: October 2, 2026, 9:26 pm

MonthDec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025Jun 2026
Equity Capital 23232323232323232323232323
Reserves 1,4631,6041,8602,0032,1962,4192,0962,2031,253992838726803
Borrowings 00000023252419191815
Other Liabilities 742778658751765802777811772681732488567
Total Liabilities 2,2282,4052,5412,7782,9843,2442,9183,0612,0721,7151,6121,2551,407
Fixed Assets 648877817769733499464334306315312304291
CWIP 210223430211710132416181219
Investments 0000000002000
Other Assets 1,3691,5051,6901,9782,2302,7282,4442,7141,7431,3821,2819391,098
Total Assets 2,2282,4052,5412,7782,9843,2442,9183,0612,0721,7151,6121,2551,407
FINANCIALS

Cash generation

Operating activities generated ₹438 crore in Dec 2025. Positive operating cash flow shows cash generated by operations in this period; examine its consistency and the capital expenditure needed to sustain the business.

Operating & free cash flow

₹ crore

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthDec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Cash from Operating Activity + 265213322435374412611559399231462438
Cash from Investing Activity + 6136-155-79-736627663165136-178-11
Cash from Financing Activity + -122-147-180-188-197-183-810-849-1,583-878-392-448
Net Cash Flow 205102-1316810429578341-533-612-109-21

Free Cash Flow Table

Free cash flow is not available in the stored cash-flow statement. Missing values are not treated as zero.

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Working-capital days were 20 in Dec 2024. That is 15 days lower than the same annual period a year earlier. Compare collection, inventory and payment cycles within this feed to understand the movement; these measures do not identify the cause by themselves.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthDec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Debtor Days 242124222921271918172442
Inventory Days 151179173169151154127107110125254186
Days Payable 83122817911911010093105109112151
Cash Conversion Cycle 927811511261655433223316777
Working Capital Days 4326979171835-8-20-193520
ROCE %29%22%26%27%26%29%28%32%35%41%44%49%
FINANCIALS

Ownership trends

Promoters held 60.40% in Jun 2026. Their share was unchanged from Jun 2025. Ownership percentages can change through share issuance as well as transactions. Check exchange disclosures for the explanation and any pledging; the percentage alone is not evidence of investor conviction.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 60.40%60.40%60.40%60.40%60.40%60.40%60.40%60.40%60.40%60.40%60.40%60.40%
FIIs 6.80%6.31%6.11%5.81%5.78%5.64%5.58%5.61%5.57%5.55%5.65%5.69%
DIIs 21.68%22.51%22.88%22.60%22.62%22.94%23.02%23.06%22.28%21.30%21.12%19.87%
Public 11.10%10.78%10.61%11.21%11.20%11.04%11.01%10.94%11.75%12.75%12.84%14.05%
No. of Shareholders 68,59862,87061,84967,66266,21166,40168,19666,79071,39575,81375,75880,005
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
SBI Contra Fund 251,576 0.21 101.08161,0002025-12-07 15:45:1656.26%
Nippon India Pharma Fund 230,272 1.17 92.52236,0082025-12-08 04:19:42-2.43%
Nippon India Growth Mid Cap Fund 226,766 0.22 91.11N/AN/AN/A
Nippon India Small Cap Fund 213,992 0.13 85.98196,3422025-12-08 07:42:138.99%
Nippon India Multi Cap Fund 152,371 0.13 61.22152,3712025-04-22 17:25:210%
SBI ELSS Tax Saver Fund 147,988 0.19 59.46N/AN/AN/A
SBI Midcap Fund 128,577 0.23 51.66195,0822026-01-26 05:01:22-34.09%
Nippon India Innovation Fund 49,110 0.73 19.73N/AN/AN/A
Sundaram Dividend Yield Fund 11,397 0.51 4.58N/AN/AN/A

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthDec 24Dec 23
FaceValue 10.0010.00
Basic EPS (Rs.) 179.46261.78
Diluted EPS (Rs.) 179.46261.78
Cash EPS (Rs.) 195.65279.35
Book Value[Excl.RevalReserv]/Share (Rs.) 374.17441.39
Book Value[Incl.RevalReserv]/Share (Rs.) 374.17441.39
Revenue From Operations / Share (Rs.) 875.301239.61
PBDIT / Share (Rs.) 220.57377.83
PBIT / Share (Rs.) 204.61360.61
PBT / Share (Rs.) 187.57367.61
Net Profit / Share (Rs.) 179.69262.13
NP After MI And SOA / Share (Rs.) 179.69262.13
PBDIT Margin (%) 25.1930.47
PBIT Margin (%) 23.3729.09
PBT Margin (%) 21.4229.65
Net Profit Margin (%) 20.5221.14
NP After MI And SOA Margin (%) 20.5221.14
Return on Networth / Equity (%) 48.0259.38
Return on Capital Employeed (%) 52.7277.98
Return On Assets (%) 25.6435.15
Asset Turnover Ratio (%) 1.210.00
Current Ratio (X) 1.571.92
Quick Ratio (X) 0.870.89
Inventory Turnover Ratio (X) 0.600.00
Dividend Payout Ratio (NP) (%) 0.00139.85
Dividend Payout Ratio (CP) (%) 0.00131.23
Earning Retention Ratio (%) 0.00-39.85
Cash Earning Retention Ratio (%) 0.00-31.23
Interest Coverage Ratio (X) 338.20511.18
Interest Coverage Ratio (Post Tax) (X) 235.27345.18
Enterprise Value (Cr.) 13783.3918147.83
EV / Net Operating Revenue (X) 6.856.37
EV / EBITDA (X) 27.1720.88
MarketCap / Net Operating Revenue (X) 6.996.51
Retention Ratios (%) 0.00-39.85
Price / BV (X) 16.3618.28
Price / Net Operating Revenue (X) 6.996.51
EarningsYield 0.020.03

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Sanofi India Ltd 6,779 Cr. 2,945 4,898/2,91419.8 3592.55 %57.5 %43.0 % 10.0
Bliss GVS Pharma Ltd 6,937 Cr. 656 745/11850.4 1130.23 %16.9 %11.8 % 1.00
Morepen Laboratories Ltd 7,096 Cr. 130 151/33.060.4 22.80.15 %8.05 %5.33 % 2.00
Entero Healthcare Solutions Ltd 7,349 Cr. 1,689 1,920/94457.0 3880.00 %10.5 %6.94 % 10.0
IOL Chemicals & Pharmaceuticals Ltd 5,900 Cr. 201 224/67.133.4 61.30.50 %11.3 %8.42 % 2.00
Industry Average17,127.26 Cr1,216.6253.25211.240.40%26.16%16.59%6.06

All Competitor Stocks of Sanofi India Ltd

Explore Industry-wise Company financial data